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Objectives. We examined whether angina pectoris occurring 
shortly before the onset of acute myocardial infarction can actually 
preserve postischemic left ventricular function in humans. 
Background. Experimental studies indicate that brief, transient 
episodes of ischemia render the heart very resistant to infarction 
from a subsequent sustained ischemic insult, an effect termed 
ischemic preconditioning. However, no clinical data are available 
concerning the implications of angina pectoris hortly before the 
onset of infarction in humans. 
Methods. We studied 84 patients with an acute anterior myo- 
cardial infarction. All patients had total occlusion of the proximal 
or medial portion of the left anterior descending coronary artery 
and achieved reflow within 6 h of onset. Patients were classified 
into three groups on the basis of duration of antecedent angina 
pectoris: group 1 = no angina (37 patients); group 2 = new angina 
pectoris occurring <7 days of onset of infarction (22 patients); 
group 3 = angina pectoris beginning >7 days before onset of 
infarction (25 patients). All patients underwent left ventriculog- 
raphy on the day of, and 28 days after, onset of infarction to 
determine ejection fraction and regional wall motion in the 
territory of the left anterior descending coronary artery by the 
centerline method. 
Results. Angiographic collateral f ow grade was higher in group 
3 than in groups 1 and 2 ([mean -+ SD] group 1 = 0.8 -+ 0.7, group 
2 = 0.7 -+ 0.7, group 3 = 1.5 -+ 0.8). Although there were no 
differences in baseline jection fraction and regional wall motion 
among the three groups, the degree of improvement was signifi- 
cantly greater in groups 2 and 3 than in group 1 (late minus 
baseline jection fraction: group 1 = 0 -+ 8%, group 2 = 7 -+ 10%, 
group 3 = 6 -+ 10% [p < 0.05 group 1 vs. groups 2 and 3]; late 
minus baseline regional wall motion: group 1 = 0.2 -+ 0.4, group 
2 = 0.6 - 0.5, group 3 = 0.5 ± 0.6 SD/chord [p < 0.05, group 1 
vs. group 2]). When the study was limited to those patients with no 
or poor collateral flow (31 in group 1, 19 in group 2, 10 in group 
3), only group 2 patients had a significant improvement in wall 
motion. Angina pectoris within 24 h before onset of infarction was 
more frequent in group 2 (82%) than group 3 (28%, p < 0.05). 
Conclusions. Episodes of angina pectoris occurring shortly 
before the onset of infarction may preserve myocardial contractile 
function in reperfused myocardial infarction despite less support 
from collateral flow channels, although these are suggestive 
results in a limited number of patients. 
(JAm Coil Cardiol 1995;25:1076-83) 
Thrombolysis and coronary angioplasty are widely performed 
in patients with acute myocardial infarction to restore coronary 
flow to the jeopardized myocardium (1). Although coronary 
reflow, if achieved in the early stage of infarction, is useful to 
limit the progression of myocardial necrosis, its effect on 
myocardial salvage varies among patients. The variation in the 
effect of coronary reperfusion can be explained by several 
factors, such as time from onset of infarction to reperfusion, 
development of collateral circulation, loading conditions to the 
left ventricle and medications (e.g., beta-adrenergic blocking 
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agents) (1-3). In addition, recent experimental studies (4,5) 
have indicated that the occurrence of brief episodes of isch- 
emia may, in itself, limit infarct size and improve functional 
recovery during a subsequent sustained coronary occlusion and 
reperfusion, an effect known as "ischemic preconditioning." 
In the clinical setting, myocardial infarction is often pre- 
ceded by an episode or episodes of angina pectoris (6,7). 
Several clinical studies (8-10) have discussed the significance 
of this antecedent angina pectoris in relation to its cardiopro- 
tective effect. In studies of nonreperfused myocardial infarc- 
tion (9-11), patients with antecedent angina pectoris occurring 
>7 days before the infarction showed better collateral circu- 
lation and smaller infarct size than those with angina pectoris 
occurring within only 7 days of the infarction (9-11). However, 
despite development of less collateral circulation, antecedent 
angina occurring shortly before the onset of myocardial infarc- 
tion can also contribute to preservation of myocardial function 
©1995 by the American College of Cardiology 0735-1097/95/$9.50 
0735- 1097(94)00542-X 
JACC Vol. 25, No. 5 NAKAGAWA ET AL. 1077 
April 1995:1076 83 ANGINA PECTORIS AND MYOCARDIAL PROTECTION 
in reperfused myocardial infarction because of cardioprotec- 
tion due to ischemic preconditioning. 
In the present study, we aimed to elucidate whether ante- 
cedent angina pectoris can indeed exert a preconditioning 
effect on the myocardium in patients with a reperfused anterior 
myocardial infarction. To examine this hypothesis, we classi- 
fied the patients into three groups on the basis of duration of 
antecedent angina pectoris (see Methods) and compared 
global and regional eft ventricular function among the three 
groups in the early and late stages after successful reperfusion. 
Methods  
Patient selection. This study was designed retrospectively. 
At our institute, we attach great importance to antecedent 
angina pectoris and have obtained etailed histories of ante- 
cedent angina in patients with myocardial infarction for several 
years. From October 1986 to November 1993, consecutive 
patients presenting with an acute anterior myocardial infarc- 
tion <5 after the onset of symptoms were considered for entry 
into the study. Inclusion criteria were 1) total occlusion 
(Yhrombolysis n Myocardial Infarction trial [TIMI] grade 0) 
of the proximal region of the left anterior descending coronary 
artery revealed by coronary arteriography performed on the 
day of infarction; 2) no previous myocardial infarction; and 3) 
successful coronary reflow (TIMI grade 3, residual diameter 
stenosis -<75%) achieved within 6 h after onset of infarction. 
Acute myocardial infarction was diagnosed on the basis of 1) 
prolonged chest pain >30 rain, 2) 2-ram ST segment elevation 
on the electrocardiogram in two or more contiguous leads; and 
3) a greater than threefold increase in serum creatine kinase 
level. Exclusion criteria were 1) >75% diameter stenosis in 
another coronary artery; 2) an ischemic event during the 
follow-up period; 3) high grade residual stenosis after reper- 
fusion (->90%); 4) >75% diameter stenosis of the infarct- 
related artery at the time of restudy; 5) in-hospital death; 6) 
positive bicycle ergometric exercise test result at the convales- 
cent stage; and 7) mechanical complications (free wall, ven- 
tricular septal or papillary muscle rupture). Eighty-four pa- 
tients (68 men, 16 women; mean age 58 years, range 38 to 82) 
met the inclusion criteria and formed the study group. Coro- 
nary reflow was achieved by intracoronary thrombolysis (uroki- 
nase, 480,000 to 960,000 U) in 13 patients and by coronary 
angioplasty in 71. In patients with thrombolysis, coronary 
reflow was confirmed by coronary angiography repeated every 
5 rain. Informed written consent was obtained from each 
patient by one of the investigators. The study protocol was 
approved by the hospital ethics committee. 
Protocol. In all patients, diagnostic oronary angiography 
followed by contrast left ventriculography (30 ° right anterior 
oblique projection) was performed using the femoral approach 
on the day of onset of infarction. After total occlusion was 
confirmed, successful coronary reflow was achieved. Coronary 
angiography and left ventriculography was repeated using the 
brachial or femoral approach 21 to 36 days (mean 28) after 
onset of infarction in all patients. 
Analysis of antecedent angina. Detailed clinical history, 
especially of cardiac symptoms before onset of infarction, in all 
patients was obtained by a staff physician. Cardiac symptoms 
included chest pain, chest discomfort and left arm and jaw 
pain. Onset of infarction was defined as the initiation of 
cardiac symptoms persisting >30 min. Cardiac symptoms that 
lasted <30 rain before onset of infarction and were considered 
of cardiac origin were defined as antecedent angina pectoris. 
Duration of antecedent angina pectoris was defined as the time 
from the first symptom to onset of infarction. The patients 
were classified into three groups on the basis of the existence 
and duration of antecedent angina pectoris: group 1 = no 
antecedent angina pectoris; group 2 = angina pectoris occur- 
ring for the first time -<7 days of infarction; group 3 = angina 
pectoris beginning >7 days of infarction. 
Analysis of catheterization data. Cine films were analyzed 
in a random sequence by an angiographer who was unaware of 
clinical findings. Coronary artery segments were identified and 
categorized according to the reporting system of the American 
Heart Association. Coronary artery diameter was measured 
with calipers on adequately magnified 35-ram cine films at 
end-diastole. 
Right anterior oblique views of left ventriculograms obtained 
before reperfusion and 4 weeks later were used for assessment 
of global and regional eft ventricular function. End-diastolic 
and end-systolic endocardial borders were hand traced in the 
frames with maximal and minimal volume, respectively. After 
left ventricular end-diastolic (LVEDV) and end-systolic 
(LVESV) volumes were calculated by the area-length method, 
left ventricular ejection fraction (%) was obtained as follows: 
(LVEDV - LVESV) × 100/LVEDV. Left ventricular end- 
diastolic volume was also corrected for body surface area to 
determine volume index (ml/m2). 
Regional wall motion from the left ventriculogram was 
assessed with the centerline method, using 100 chords (12). 
Each shortening fraction was normalized by the end-diastolic 
perimeter of the left ventricle at end-systole. This normalized 
wall motion in the territory of the left anterior descending 
coronary artery (chords i0 to 66) was expressed as the standard 
deviation from the mean value previously determined in 38 
age-matched normal subjects (regional wall motion: SD/chord) 
(13). 
Collateral channels at initial angiography were graded by 
consensus of two angiographers who had no knowledge of 
clinical findings: 0 = no collateral vessels; 1= incomplete slow 
opacification of the distal vessel; 2 = slow but complete 
opacification of the distal vessel; 3 = distal vessel well opaci- 
fled to the same degree as the normal vessel. 
Statistical analysis. All data are expressed as mean value _+ 
SD. When data were compared among the three groups, 
one-way analysis of variance for factor analysis and the Scheff6 
F test were applied. Comparisons between results of baseline 
and delayed studies were performed by analysis of variance 
and the Scheffd F test for repeated measures. The contribution 
of factors that may influence ischemic myocardial damage to 
the improvement in systolic function was evaluated by multi- 
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Table 1. Clinical Characteristics of 84 Study Patients 
Antecedent Angina Pectoris 
Group 1 Group 2 Group 3 
(none) (-<l wk) (>1 wk) 
(n = 37) (n - 22) (n 25) 
Age(yr) 56± 11 59+ 11 58-9  
Gender (% male) 81 77 84 
Time interval (onset to 3.9 + 1.3 4.7 _+ 0.9 4.2 + 1.3 
repcrfusion) (h) 
Culprit (6/7) 23/14 12/111 I7/8 
Collateral grade 0.8 = I).7" 11.7 _+ 0.7* 1.5 ± (I.8 
Reperfusion therapy 5/23 5/17 3/22 
(t hrombolysis/'angioplasty,) 
Residual coronary stenosis (%) 26 + 2(I 28 + 19 27 + 20 
Coronary. stenosis at F/'U (%) 39 + 25 35 + 23 41 ± 20 
Previous medications (%) 
Beta-blockers 8 9 16 
Ca-channel antagonists 11 18 36 
Nitrates 8 lg 28 
Aspirin 3 5 8 
Risk factors (%) 
Diabetes mellitus 3(I 18 36 
Hypcrlipidemia 311 27 40 
Hypertension 30 50 40 
Smoking 51 50 40 
*p < 0.05 versus group 3. Patients arc subgrouped according to duration of 
preinfarction angina pectoris (see text for details). Data presented are mean 
value + SD, unless otherwise indicated. Ca calcium; Culprit 6/7 - number of 
lesions proximal and distal to the first septal perforator, respectively; F/U = 
follow-up. 
variate regression analysis, as shown later. For all analyses, p < 
0.05 was considered significant. 
Resu l t s  
Antecendent angina. Thirty-seven patients (44%) had no 
antecedent angina pectoris (group 1); 22 (26%) had anteced- 
ent angina pectoris occurring for the first time -<7 days of 
infarction (group 2); and 25 (30%) had antecedent angina 
pectoris >7 days of infarction (group 3). 
Clinical and angiographic characteristics. Table 1 shows 
the clinical and angiographic haracteristics and medications in 
the three groups. There were no differences in variables, except 
angiographic ollateral grade, which was higher in group 3 than 
in groups 1 and 2. 
Changes in left ventricular function. Table 2 summarizes 
changes in left ventricular ejection fraction, end-diastolic vol- 
ume index and regional wall motion in the three groups. 
Ejection fraction, end-diastolic volume index and regional wall 
motion did not differ among the three groups at baseline. 
There was no change in ejection fraction between the early and 
late stages in group 1, whereas groups 2 and 3 had a significant 
increase in ejection fraction at the late stage. End-diastolic 
volume index increased in group 1, but no left ventricular 
dilation was observed in groups 2 and 3. Regional wall motion 
improved in all groups during the late stage, with greater 
improvement in group 2 than group 1. 
Table 2. Changes in Variables Derived From Left Ventriculography 
(all patients) 
Antecedent Angina Pectoris 
Group 1 Group 2 Group 3 
(none) (<1 wk) (>1 wk) 
LVEF (%) 
Early 
Late 
Late minus early 
p value 
LVEDVI (ml/m 2) 
Early 
Late 
p w~luc 
RWM (SD/chord) 
Early 
Late 
Late minus early 
p value 
43±8 43± 11 44_+10 
43 _+ 9 50 + 14 50_+ 12 
0 + 8 7 = 10' 6 + 10' 
NS <0.001 <0.01 
90 + 21 86 ± 20 77 ± 11 
100 : 22 94 + 23 83 -+ 17 
<0.01 NS NS 
-334 + 0.40 -3.34 ±/I.66 -3.22 ± 0.69 
3.14 _+ 11.45 -2.72 ± 0.75 -2.70 _+ 0.89 
0.21 + 0.47 /).62 ± 0.55* 0.52 ± 0.60 
<0.01 <0.0(ll <11.01 
*p < 0.05 versus group 1. Data presented are mean value _+ SD. LVEDVI = left 
ventricular end-diastolic volume index; LVEF = left ventricular ejection frac- 
tion; p value - early versus late; RWM = regional wall motion. 
Although collateral flow grade did not differ between 
groups 1 and 2 in the early stage (Table 1), group 2 had greater 
improvement in left ventricular function than group 1. There- 
fore, the degree of collateral development cannot explain the 
difference in functional recovery between the two groups. To 
strengthen this observation, we further assessed changes in left 
ventricular ejection fraction and regional wall motion in pa- 
tients with no functionally significant collateral vessels (collat- 
eral grade 0 or 1) at initial coronary arteriography (Table 3, 
Figs. 1 and 2). Among these selected patients (31 patients in 
group l, 19 in group 2, 10 in group 3), there was no significant 
improvement in global or regional function in group 1 and 3 
patients. Only group 2 showed a significant improvement in 
these variables in the late study, with greater improvement in 
group 2 than group 1. These results suggest hat the greater 
Table 3. Changes in Variables Derived From Left Ventriculography 
(patients with no or poor collateral circulation) 
Antecedent Angina Pectoris 
Group l Group 2 Group 3 
(none) (-<1 wk) (>1 wk) 
LVEF (%) 
Early 43 _'_ 8 43 --- 12 46 ± 10 
Late 42 ± 8 50 ± 15 50 -+ 14 
Late minus early 0 _+ 8 7 ± 10" 4 + 12 
p value NS <0.05 NS 
RWM (SD/chord) 
Early -3.32 + 0.40 3.33 ± 0.71 -2.96 + 0.83 
Late -3.17 = 0.44 2.70 + 0.80 -2.51 _+ 1.1l 
Late minus early 0.15 ± 0.48 0.64 ± 0.59* 0.45 + 0.77 
p value NS <0,(101 NS 
*p < 0.05 versus group 1. Data presented are mean value _+ SD. Abbrevi- 
ations as in Table 2. 
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Figure 1, Plots of left ventricular ejection fraction at early and late 
stages of infarction in patients with no or poor collateral circulation at 
initial coronary angiography. Squares = patients with angina attack 
within 24 h of onset of infarction; Circles and vertical bars = mean 
value + SD. Group 1 = no antecedent angina pectoris; Group 2 = 
angina pectoris occurring within 7 days of infarction; Group 3 = 
angina pectoris present >7 days before infarction. 
functional recovery in group 3 is attributable to the develop- 
ment of collateral vessels, but the comparable extent of 
functional recovery in group 2 is attributable to a factor other 
than collateral vessels. 
Clinical data for groups 2 and 3. The clinical data for 
group 2 patients are summarized in Table 4. Data are arranged 
Regional Wall 
Motion n.s. p < 0.01 
(SD/Chord" r 1 r - -q  
o 
-2 
-3 
-4 
-5 
T 
n,s,  
l - -1  
acute late acute late acute late 
Group 1 Group 2 Group 3 
Figure 2. Plots of regional wall motion in the territory of the left 
anterior descending coronary artery at the early and late stages in 
patients with no or poor collateral circulation at initial coronary 
angiography. Symbols and abbreviations a in Figure 1. 
according to the time interval from the last episode of angina 
pectoris to onset of infarction. The last episode of angina 
pectoris was observed within 24 h of onset of infarction in 18 
(82%) of 22 patients. Seven patients had multiple episodes of 
angina pectoris (unstable state) within 24 h before onset of 
infarction. Improvement in global and regional eft ventricular 
function tended to be greater in patients with antecedent 
angina within 24 h than in those with angina observed >24 h 
Table 4. Clinical Characteristics of Patients in Group 2 
LVEF (%) RWM (SD/chord) 
Age (yr)/ Episodes -<7 days Episodes -<24 h Last Angina Onset to Collateral Culprit 
Gender Before AMI Before AMI Onset (h) Reflow (h) Flow Grade Lesion Ear ly Convalescent Ear ly Convalescent 
56/F 2 2 2.5 6 1 7 54.5 63.8 -2.95 -2.75 
50/M 2 l 3 4.5 0 7 37.4 45.4 -3.73 2.88 
68/M I 1 3 4.5 1 6 41.5 34.3 -2.73 -2.77 
82/M 2 1 4 5.1 1 6 42.9 68.3 -4.2 - 1.98 
62/M 3 1 5 3.8 0 6 34.5 45.1 -3.87 -3.17 
67/M 4 3 5 5 2 6 40.7 48.3 -3.69 -3.04 
49/M 3 2 5 5.4 0 6 29.8 43.7 -3.58 -2.79 
44/M 1 1 5.5 5.7 1 7 45 57.8 -3.3 -2.87 
57/M 2 2 7 5.5 0 7 60.6 73.4 -2.31 -0.86 
61/M I 1 8 5.4 2 7 38.9 49 -3.26 -2.66 
52/M 3 3 11.5 4.5 2 6 40.6 49 3.29 -2.9 
42/M 2 1 13 4 0 6 39.7 46.3 -3.46 -3.12 
73/F I 1 15 5.3 1 6 43.3 38.5 - 3.69 3.6 
55/M 4 2 17 4.6 1 7 46 45 -3.46 -3.1 
65/M 1 1 18.5 3.8 0 7 40.1 40.4 -3.61 3.44 
66/~ 2 1 22 5.8 1 7 34.7 36 -3.57 -3.32 
66/M 1 1 23.5 3 0 6 45.8 49.9 -3.34 -2.88 
46/M 1 1 48 6 1 6 75.1 85.4 -1.42 -0.62 
65/M 1 0 48 3.6 0 6 62.8 57.3 -2.29 -2.13 
63/M 1 0 120 6 1 6 31.3 39.6 -3.85 -2.91 
77/F 1 0 168 4 0 7 31.2 23 -3.72 3.42 
Culprit = preseptal (6), postseptal (7); Episodes = number of episodes of antecedent angina pectoris: F = female; M = male; other abbreviations as in Table 2. 
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Figure 3. Time interval between the last episode of angina pectoris 
and onset of infarction in groups 2 and 3. The time interval is shorter 
in group 2 than group 3. Data are expressed as mean value _+ SD. 
Abbreviations as in Figure 1. 
before onset of infarction (late minus baseline jection fraction 
8.2 _+ 9.3 vs. 1.6 _ 9.9% SD/chord; late minus baseline regional 
wall motion 0.64 _+ 0.38 vs. 0.55 _+ 0.48 SD/chord). 
Figure 3 shows the time from the last episode of angina 
pectoris to onset of infarction in groups 2 and 3. The mean 
interval in group 2 was markedly shorter than that in group 3 
(25 vs. 314 h). Episodes of angina pectoris within 24 h of onset 
of infarction were observed more frequently in group 2 than 
group 3 (82% vs. 28%, p < 0.05). 
Variables contributing to recovery of left ventricular func- 
tion. Multivariate regression analysis was performed to eval- 
uate the contribution of each variable to the recovery of 
cardiac function, as shown in Table 5. We hypothesized that 
the preconditioning effect would decrease with the duration 
between the last episode of angina pectoris and onset of 
infarction. Therefore, the reciprocal of the duration between 
the last episode of angina pectoris and onset of infarction was 
used as the score of antecedent angina, so no antecedent 
angina was scored as 0. 
Multivariate analysis identified only antecedent angina pec- 
toris score (p = 0.003) as the significant predictor of increase 
in left ventricular ejection fraction from baseline to late 
studies. Multivariate analysis further identified degree of col- 
lateral flow (p = 0.0405) and score of antecedent angina 
pectoris core (p = 0.008) as the two significant predictors of 
increase in regional wall motion. However, these variables 
together could account for <30% of the total improvement in
left ventricular function. Other, still unknown variables need to 
be identified to explain the variability of the reperfusion effect. 
Discuss ion  
Patient selection and study protocol. Preservation of post- 
ischemic left ventricular function is determined by several 
factors other than the presence or absence of antecedent 
angina pectoris, such as collateral circulation; patency of the 
infarct-related artery; residual coronary stenosis; time from 
onset of infarction to reperfusion; and postreperfusion therapy 
or events, or both. In the present study, we aimed to elucidate 
whether the presence of episodes of angina pectoris shortly 
before onset of infarction could itself yield preconditioned 
myocardium that is more resistant to subsequent ischemia than 
Table 5. Multiple Regression Analysis 
DLVEF DRWM 
Variable (p value) (p value) 
Score of antecedent angina pectoris 0.0030 0.0080 
Collateral flow grade 0.0663 0.0405 
Interval (onset o reperfusion) 0.0973 0.2941 
Gcnder 0.6429 0.6852 
Reperfusion therapy (thrombolysis v . angioplasty) 0.2087 0.0785 
Age 0.6429 0.8122 
Percent residual coronary, stenosis 0.6441 0.2941 
Percent corona D' stenosis at time of restudy 0.4260 0.6890 
Previous medications 
Nitrates 0.3920 0.5075 
Ca-channel antagonists 0.4667 0.1758 
Beta-blockers 0.4786 0.7115 
Aspirin 0.3743 0.4250 
Medications after repcffusion (angiotensin-converting e zyme inhibitions) 0.8638 0.9880 
R 2 [I.275 1).265 
Collateral flow grade 0 (none) to 3 (good); DLVEF = left ventricular ejection fraction (late minus early); 
DRWM = regional wall motion (late minus early); Previous medications =0 (none), 1 (positive); Reperfusion therapy = 
0 (thrombolysis), 1 (angioplas~); Score of antecedent angina pectoris (/h) 1/(time interval between last episode of 
angina and onset of infarction). 
JACC Vol. 25, No. 5 NAKAGAWA ET AL. 1081 
April 1995:1076-S3 ANGINA PECTORIS AND MYOCARDIAL PROTECTION 
"virgin" myocardium. To normalize factors other than the 
presence of antecedent angina pectoris, we selected patients 
who had "total" occlusion of the left anterior descending 
coronary artery confirmed by initial coronary arteriography 
and achieved early (<6 h) and successful (residual stenosis 
<75%) coronary repeffusion. Additionally, we excluded pa- 
tients with recurrent ischemia, mechanical complications and 
in-hospital death because these postreperfusion events were 
considered to affect functional improvement. 
In addition, because antecedent angina pectoris possibly 
contributes tothe preservation of myocardial integrity through 
the development of collateral circulation (8-11), we classified 
the study patients into three groups on the basis of duration of 
antecedent angina pectoris to evaluate the role of collateral 
development i  the recovery of left ventricular function. This is 
based on previous observations (11,14) that development of
collateral circulation was greater in patients with antecedent 
angina pectoris occurring >7 days before infarction (group 3) 
than in those without antecedent angina pectoris (group 1) or 
those with angina pectoris occurring within 7 days of the 
infarction (group 2). In fact, in the present study, group 3 
patients exhibited well developed collateral circulation. This 
observation explains the greater improvement i  left ventricu- 
lar function after eperfusion i group 3 than group 1 patients. 
Implications of antecedent angina pectoris. Experimental 
studies (15) have demonstrated that episodes of brief ischemia 
before more prolonged ischemia result not only in reduced 
infarct size, but also in significantly better ecovery of systolic 
function (15). However, there have been limited clinical data 
as to whether preconditioning can actually preserve wall 
motion in reperfused hearts, the ultimate goal of any salvage 
intervention. In patients with reperfusion, our data demon- 
strated that groups 2 and 3 had greater improvement i  global 
and regional eft ventricular function than group 1. Collateral 
circulation played an important role in the preservation of
contractile function in group 3. The greater improvement in 
left ventricular function in group 2 than group 1 cannot be 
explained by collateral circulation, time from onset infarction 
to reperfusion or preinfarction medication. Therefore, our 
data suggest hat antecedent angina pectoris, in itself, may 
exert a beneficial effect on the preservation of postischemic 
myocardial function aside from collateral circulation. 
To strengthen these observations, we compared the im- 
provement in left ventricular function after eperfusion among 
selected patients who had grade 0 or 1 collateral circulation. As 
a result, only group 2 patients howed significant improvement 
in left ventricular function, in contrast o group 1 and 3 
patients with little or no improvement. Therefore, antecedent 
angina pectoris shortly before infarction indeed exerted a 
cardioprotective effect in group 2 in addition to collateral 
circulation, which also played an important role in preservation 
of myocardial function in group 3. Although these are sugges- 
tive results in a limited number of patients, to our knowledge 
this is the first report to document the presence of precondi- 
tioning in humans. 
The mechanism of preconditioning is not fully understood. 
Preconditioning does not simply accrue from the energy sav- 
ings associated with turning off the contractile machinery, 
which is depressed shortly after the onset of occlusion (16). 
Several studies (17-20) indicate that adenosine release from 
the ischemic myocardium plays a significant role in preserving 
the integrity of the myocardium and microcirculation. A recent 
experimental study (21) indicated that augmentation f the 
synthesis of proteins, such as manganese uperoxide dismutase, 
may contribute to the preconditioning effect observed 24 h 
after a brief episode of ischemia (21). 
Type of angina pectoris and preconditioning. In a canine 
experiment, Murry et al. (4) demonstrated that much of the 
protective ffect was lost if the time between the precondition- 
ing episode(s) of brief ischemia nd the later sustained isch- 
emia was extended for several hours. This observation indi- 
cates the possibility that the preconditioning effect of angina 
pectoris is lost if the time interval from the last episode of 
angina pectoris and onset of infarction exceeds acertain time 
limit. In contrast, Kuzuya et al. (21) recently demonstrated that 
after the initial preconditioning effect was lost, the delayed 
preconditioning effect appeared 24 h after a brief episode of 
ischemia, and, at that time, the synthesis of manganese uper- 
oxide dismutase was augmented. Therefore, it is important to 
determine how angina pectoris exerts a preconditioning effect 
on the ischemic myocardium in humans. 
We first investigated the time interval from the last episode 
of angina pectoris to the onset of infarction in group 2 and 
compared the results with those in group 3, in whom collateral 
circulation played a significant role in myocardial protection. 
This time interval was markedly shorter in group 2 than group 
3. Moreover, the majority (82%) of group 2 patients had 
episodes of angina pectoris within 24 h of infarction, in 
contrast o only 28% of group 3 patients. Among group 2 
patients, the improvement in left ventricular function tended 
to be greater in those with than without an anginal episode 
within 24 h before onset. In addition, group 3 patients with 
antecedent angina within 24 h of onset of infarction had 
somewhat greater improvement in left ventricular function 
than those without angina within 24 h before onset (data not 
shown). Therefore, the interval between the episode of last 
angina pectoris and onset of infarction seems to determine 
whether angina pectoris can exert a preconditioning effect. Our 
data also imply that antecedent angina pectoris within 24 h can 
indeed preserve myocardial contractile function in the clinical 
setting. 
We examined whether a shorter interval between the last 
episode of angina pectoris and onset of infarction results in 
greater improvement in left ventricular function. We deter- 
mined the antecedent angina score, defined as the reciprocal of 
the interval, and compared several variables, including this 
score, with the degree of increase in ejection fraction or 
regional wall motion by multivariate analysis. Our data indi- 
cated that antecedent angina pectoris and grade of collateral 
flow contribute to improvement in ventricular function after 
reperfusion and, in particular, that the cardioprotective effect 
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of angina pectoris becomes weaker as the time interval be- 
tween the last angina attack and onset of infarction increases. 
Medical treatment. Medical treatment before acute myo- 
cardial infarction may also contribute to the reduction in 
infarct size. In particular, administration of a beta-adrenergic 
blocking agent as pretreatment before a coronary occlusion is 
reported to be beneficial in limiting the size of myocardial 
infarction (3). Functional improvement in left ventricular 
function after reperfusion i  group 2 was equal to that in group 
3 in the present study, but beta-blocker use in group 2 (7%) 
was not as frequent as that in group 3 (30%). In contrast, 
angiotensin-converting enzyme inhibitors may improve left 
ventricular function after reperfusion (22). However, there was 
no difference in angiotensin-converting e zyme inhibitor use 
after infarction among the three groups (8%, 9% and 0%, 
respectively, for groups 1, 2 and 3). 
Study limitations. It is sometimes difficult to determine the 
exact time of onset of infarction in patients with unstable 
angina with frequent angina pectoris at rest. In such patients, 
it may not be possible to differentiate preinfarction and post- 
infarction angina simply from symptoms. In the present study we 
arbitrarily defined the onset of ~mptoms with duration >30 min 
as the onset of infarction. In addition, we utilized the release 
pattern of creatine kinase and temporal changes in ECGs, if 
available, for the confirmation of onset of infarction. 
Objective markers of antecedent angina pectoris were not 
obtained in all study patients because most patients were 
admitted to our hospital only after onset of myocardial infarc- 
tion. However, in two patients (11%) in group 2, ECGs were 
recorded uring an anginal attack during the previous hospital 
admission. The ST segments were elevated in the precordial 
leads during the attack and returned to baseline after remis- 
sion of chest pain. 
It is well known that myocardial ischemia is not always 
symptomatic. Ambulatory ECG monitoring has demonstrated 
that myocardial ischemia is asymptomatic in 10% to'40% of 
events (23,24). Moreover, myocardial infarction, in itself, is 
reported to be asymptomatic in 30% of patients (25). Because 
our study was based on a detailed history of symptoms of 
cardiac origin from each patient, the significance of this silent 
ischemia could not be evaluated. 
It is difficult to quantitate myocardial infarction size as 
performed in earlier experimental studies because infarct size 
reflects ventricular function in the late stage, but residual eft 
ventricular function is a major determinant of prognosis (26). 
We therefore compared the improvement in postischemic left 
ventricular global and regional function among the three 
categories of antecedent angina pectoris to evaluate the car- 
dioprotective effect of antecedent angina pectoris. 
Visualization of collateral vessels by coronary angiography 
is affected by several factors, and there may be some collateral 
channels that cannot be detected. However, angiographic 
assessment of collateral flow grade is still the reference stan- 
dard in the clinical setting. 
Clinical implications. In the clinical setting, acute myocar- 
dial infarction is often preceded by episodes of angina pectoris. 
As shown in the present study, antecedent angina pectoris 
could be a favorable sign in terms of preservation of left 
ventricular function, regardless of the duration of antecedent 
angina. Long-standing angina pectoris plays an important role 
in allowing greater development of collateral circulation, 
thereby improving left ventricular function after coronary 
reperfusion. By contrast, episodes of angina pectoris that occur 
shortly before onset of infarction may precondition the myo- 
cardium without the development of collateral circulation, 
and, in so doing, may decrease the extent of cell death after 
onset of infarction and slow the early progression of cell death 
(4,16). A slower progression of cell death implies a longer 
window of time during which it may be possible to salvage the 
myocardium through reperfusion, such as thrombolysis or 
coronary angioplasty. Such patients may also have an increased 
time frame for successful emergency coronary artery bypass 
graft surgery and revascularization. 
We thank Rie Nishizawa for preparation f the manuscript. 
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